trial

Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study

NCTId NCT00567281
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (actual)
Sponsored by Yale University
Primary completion 2012-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2007-10
Primary completion
2012-09
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Magstim Rapid 2 system triggering Magstim Super Rapid systemMagstim Rapid-2 system triggering Magstim Super Rapid system

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ralph E. Hoffman, MDPrincipal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2012-09
Status
COMPLETED
relationships
The graph out of here
drug
Magstim Rapid 2 system triggering Magstim Super Rapid system
drug
Magstim Rapid-2 system triggering Magstim Super Rapid system
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Hallucinations
indication
Schizophrenia
indication
investigator
Ralph E. Hoffman, MD
person